Key facts
- This page summarizes Alan Connolly's Form 4 filing for CRH PUBLIC LTD CO (CRH).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 Mar 2025, 16:30.
Alan Connolly - 03 Mar 2025 Form 4 Insider Report for CRH PUBLIC LTD CO (CRH)
- Reporting relationship
- Interim Chief Financial Officer
- Issuer ticker
- CRH
- Reported as of
- 03 Mar 2025
- Net transaction value
- -$2,295,071
- SEC form
- 4
- Accepted by SEC
- 05 Mar 2025, 16:30:14 UTC
- Prior SEC filing
- 02 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Cot Eversole, Attorney-in-Fact for Alan Connolly
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Alan Connolly filed Form 4 for CRH PUBLIC LTD CO (CRH) on 05 Mar 2025.
Change
- Previous filing in this sequence was filed on 02 Jan 2025.
- Current net transaction value: -$2,295,071.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CRH
transaction
Ordinary Shares
Award
- Transaction value
- $0
- Shares
- +22,298
- Change %
- +43%
- Price
- $0.000000
- Shares after
- 74,511
- Date
- 03 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
CRH
transaction
Ordinary Shares
Tax liability
- Transaction value
- $1,195,808
- Shares
- -11,618
- Change %
- -16%
- Price
- $102.93
- Shares after
- 62,893
- Date
- 03 Mar 2025
- Ownership
- Direct
- Footnotes
- F2, F3
CRH
transaction
Ordinary Shares
Sale
- Transaction value
- $1,099,262
- Shares
- -10,680
- Change %
- -17%
- Price
- $102.93
- Shares after
- 52,341
- Date
- 03 Mar 2025
- Ownership
- Direct
- Footnotes
- F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Reflects the vesting and release of awards granted in 2022 under the 2014 Performance Share Plan Rules on March 3, 2025 (including the award of 2,261 additional Ordinary Shares as dividend equivalents), pursuant to certification of the achievement of pre-established performance goals by the Compensation Committee of the Board of Directors of the Issuer.
Footnote F2
Mandatory sale of sufficient Ordinary Shares to cover applicable withholding tax liabilities arising in the connection with the aforementioned award.
Footnote F3
The reported price represents the volume-weighted average price of shares sold. Sale prices for the reported transaction ranged between $102.30 and $103.535 inclusive of shares sold on the New York Stock Exchange. Full information regarding the number of Ordinary Shares sold at each separate price in the range will be provided to the SEC upon request.
Footnote F4
The reported price represents the volume-weighted average price of shares sold. Sale prices for the reported transaction ranged between $102.30 and $103.535 inclusive of shares sold on the New York Stock Exchange. Full information regarding the number of Ordinary Shares sold at each separate price in the range will be provided to the SEC upon request.
Footnote F5
Includes 128 Ordinary Shares purchased by AC Employee Benefit Trustees Limited, as trustee for and on behalf of the Reporting Person, as sole beneficiary, pursuant to an Irish Revenue-approved broad-based employee share participation scheme. Such Ordinary Shares are subject to a minimum holding requirement of one year.
SEC remarks
Interim Chief Financial Officer